Showing results (411-420 of 431) with videos related to

Sort By:
Pageof 44
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Development (Cambridge, England)|February 26, 2010
Runx1 and Runx2 cooperate during sternal morphogenesisAyako Kimura, Hiroyuki Inose, Fumiko Yano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Nature Structural & Molecular Biology|January 8, 2020
A bipartite structural organization defines the SERINC family of HIV-1 restriction factorsValerie E Pye, Annachiara Rosa, Cinzia Bertelli, et al.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
Gene Therapy|July 15, 2025
hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Xenotransplantation|September 2, 2014
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantationMee Kum Kim, Hyuk Jin Choi, Ivo Kwon, et al.
PLOS Digital Health|May 3, 2024
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general populationNaotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, et al.
Pageof 44